UNSPSC 51283213: Mirosamicin

This classification denotes a macrolide antibiotic with the molecular formula C37H61NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K7G02HKM1X, chemically known as 4,17-dioxabicyclo(14.1.0)heptadeca-6,14-diene-5,13-dione, 2-(((6-deoxy-2,3-di-o-methyl-beta-d-allopyranosyl)oxy)methyl)-3-ethyl-2-hydroxy-8,10,12-trimethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranosyl)oxy)-, (1r,2s,3r,6e,8s,9s,10s,12r,14e,16s)- but generally known as mirosamicin, which bears US NIH Compound Identifier 6436150.

UNSPSC 51283213 Mirosamicin is a Commodity code for a specific antibiotic pharmaceutical product, yet the most recent state and local procurement activity tagged to this code shows no actual solicitation or award of mirosamicin itself. Instead, the tagged opportunities reflect purchases of unrelated pharmaceutical products — a completed piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride through an Illinois Department of Public Health consortium award, and an older Seminole County, Florida IFB for Naloxone and drug deactivation systems. The mismatch suggests the code is either misapplied in state and local procurement systems or that mirosamicin demand through state and local channels is too sparse to generate recent solicitation activity. No recent open solicitations for mirosamicin itself appear in the available data.

The issuing bodies engaging with this code tier include state health departments and county health authorities. Geographic spread is limited to Illinois and Florida based on recent records, though this reflects the narrow activity sample. Without current open solicitations for mirosamicin, there is no representative recent opportunity to cite. State and local procurement professionals should verify whether their target markets classify mirosamicin purchases under this code, or whether supply chains for this pharmaceutical operate through different UNSPSC categories or cooperative purchasing agreements not reflected in recent public notices.